Bioinformatics market still exploding with growth; ALS trial database expanding;

> BCC Research projects the bioinformatics market to more than double in the coming years, jumping from almost $3.2 billion in 2012 to $7.5 billion by 2017, with demand for bioinformatics driven by a need to commercialize life sciences data in genomics and other fields. Item

> With clinical trial datasets from Novartis ($NVS) and others, an open access platform has emerged with data from more than 8,500 identity-free patient cases in an effort to support clinical studies of the complex neurodegenerative disease called amyotrophic lateral sclerosis. Article

> Cisco Canada ($CSCO) will award $2.1 million to McMaster University in Ontario to support research of integrated health biosystems and bioinformatics. Release

> Scale-up Systems has partnered with ScienView to provide Scale-up software for training and process development to the fast-growing pharma industry in China. Release

> TrialReach, a provider of online software for clinical trials, has raised £2 million from new investor Octopus and previous backer Amadeus Capital Partners. Item

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.